BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 12886712)

  • 21. [Polyarthritis and papular eruption revealing leprosy].
    Meyer M; Ingen-Housz-Oro S; Ighilahriz O; Wendling J; Gaulier A; Levy-Weil F; Sigal-Grinberg M; Flageul B
    Rev Med Interne; 2008 Mar; 29(3):242-5. PubMed ID: 17976874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First report of leprosy presenting as acute polyarthritis in the setting of type I downgrading lepra reaction.
    Al-Raqum HA; Uppal SS; El Abdalghani RA; Lasheen I
    Clin Rheumatol; 2006 Feb; 25(1):101-5. PubMed ID: 16247582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [What is your diagnosis? Sensory motor polyneuropathy in borderline leprosy. Trophic skin disorders with ulcerations, local superinfection on the right foot with right inguinal lymphadenopathy].
    Siccoli M; Bassetti C
    Praxis (Bern 1994); 2002 Jan; 91(3):49-52. PubMed ID: 11845612
    [No Abstract]   [Full Text] [Related]  

  • 24. A case of leprosy mistaken for cutaneous sarcoidosis.
    Aftab H; Nielsen SD; Nielsen SL; Due E; Bygbjerg IC; Thybo S
    Acta Derm Venereol; 2012 Mar; 92(2):189-90. PubMed ID: 22101923
    [No Abstract]   [Full Text] [Related]  

  • 25. Some unusual type 2 reactions in leprosy.
    Ramesh V; Pahwa M
    Int J Dermatol; 2010 Feb; 49(2):172-5. PubMed ID: 20465641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of Hansen Disease presenting as tinea versicolor.
    Yang S; Makredes M; O'Donnell P; Levin NA
    Dermatol Online J; 2013 Apr; 19(4):7. PubMed ID: 24021367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type I reaction in a borderline leprosy case successfully treated with multidrug therapy and ofloxacin.
    Asz-Sigall D; López-García L; Neme-Yunes Y; Yuen-Palos R; Vega-Memije ME; Arenas R
    Int J Dermatol; 2008 Oct; 47(10):1084-6. PubMed ID: 18986365
    [No Abstract]   [Full Text] [Related]  

  • 28. Lupus vulgaris and borderline tuberculoid leprosy: an interesting co-occurrence.
    Rao GR; Sandhya S; Sridevi M; Amareswar A; Narayana BL;
    Indian J Dermatol Venereol Leprol; 2011; 77(1):111. PubMed ID: 21220903
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hansen's disease: case report and review of literature].
    Concha R M; Cossio T ML; Salazar S I; Fich S F; Pérez C C; González B S
    Rev Chilena Infectol; 2008 Feb; 25(1):64-9. PubMed ID: 18273528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Borderline lepromatous leprosy in an Italian man.
    Massone C; Clapasson A; Nunzi E
    Am J Trop Med Hyg; 2013 Feb; 88(2):211. PubMed ID: 23390219
    [No Abstract]   [Full Text] [Related]  

  • 31. Facial tuberculoid leprosy: case report.
    Ali K; Sittampalam G; Malik MA
    Br J Oral Maxillofac Surg; 2011 Jan; 49(1):70-2. PubMed ID: 20188445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presence of Mycobacterium leprae in epidermal cells of lepromatous skin and its significance.
    Satapathy J; Kar BR; Job CK
    Indian J Dermatol Venereol Leprol; 2005; 71(4):267-9. PubMed ID: 16394437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinguishing between relapse and late reversal reaction in multidrug (MDT)-treated BT leprosy.
    Waters MF
    Lepr Rev; 2001 Sep; 72(3):250-3. PubMed ID: 11715270
    [No Abstract]   [Full Text] [Related]  

  • 34. Lest we forget Hansen's disease (leprosy): an unusual presentation with an acute onset of inflammatory polyarthritis and the rheumatology experience.
    Sheetal S; Arvind C
    Int J Rheum Dis; 2009 Apr; 12(1):64-9. PubMed ID: 20374320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persister studies in leprosy patients after multi-drug treatment.
    Gupta UD; Katoch K; Singh HB; Natrajan M; Katoch VM
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):100-4. PubMed ID: 16830652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.
    Goulart IM; Reis AC; De Rezende TM; Borges AS; Ferreira MS; Nishioka SA
    Lepr Rev; 2005 Jun; 76(2):167-9. PubMed ID: 16038251
    [No Abstract]   [Full Text] [Related]  

  • 37. Rate of decline in bacterial index in leprosy; observations after three different chemotherapeutic interventions.
    Ganapati R; Pai VV; Shroff HJ; Gandewar K
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):264-6. PubMed ID: 9251604
    [No Abstract]   [Full Text] [Related]  

  • 38. Single-dose treatment for paucibacillary leprosy; field implications.
    Revankar CR; Pai VV; Samy MS; Ganapati R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):312-4. PubMed ID: 10575415
    [No Abstract]   [Full Text] [Related]  

  • 39. Leprosy in transplant recipients: report of a case after liver transplantation and review of the literature.
    Trindade MA; Palermo ML; Pagliari C; Valente N; Naafs B; Massarollo PC; D'Albuquerque LA; Benard G
    Transpl Infect Dis; 2011 Feb; 13(1):63-9. PubMed ID: 20678090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Leprosy - An overview from a pediatric perspective].
    Magdorf K; Haas WH; Harms D; Höger PH; Griese M; Rank M
    Klin Padiatr; 2001; 213(5):266-70. PubMed ID: 11582524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.